UnknownNot Applicable

Evolutionary Systems Therapy for Schizotypy

Italy28 participantsStarted 2022-10-05

Plain-language summary

This study aims at replicating existing preliminary evidence about the effectiveness of Evolutionary Systems Therapy for Schizotypy (ESTS). The present randomized controlled trial (RCT) will compare ESTS with Cognitive Behavioral Therapy (CBT) in treating Schizotypal Personality Disorder (SPD). The main questions our RCT aims to answer are: 1. Is ESTS more effective than CBT in treating SPD? 2. Is ESTS more feasible than CBT in treating SPD? 38 patients diagnosed with SPD will be recruited and randomly allocated to either the experimental group (i.e. ESTS) or the control group (CBT). Primary outcome will be reduction in general symptomatology, whereas secondary outcomes will be changes in target mechanisms (self-criticism and metacognition) and remission from diagnosis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of Schizotypal Personality Disorder at SCID-5-AMPD Module III * Age 18 or older * Being capable of reading and signing the inform consent form in Italian * Being capable of attending a talk therapy in Italian Exclusion Criteria: * Being diagnosed with schizophrenia spectrum disorders or other psychosis disorder * Being diagnosed with neurodevelopmental or neurological disorders * Being diagnosed with bipolar disorder * Being under any psychological or pharmacological treatment

What they're measuring

Change in general symptomatology

Timeframe: 2 measurements: one at baseline assessment; one at final assessment

Trial details

NCT IDNCT05710926

SponsorTages Onlus

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-11-01

Contact for this trial

Simone Cheli, PhD

+393285642442 simone.cheli@tagesonlus.org